SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-177174
Filing Date
2021-05-28
Accepted
2021-05-28 17:03:37
Documents
18
Period of Report
2021-05-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d173882d8k.htm   iXBRL 8-K 44109
2 EX-1.1 d173882dex11.htm EX-1.1 197819
3 EX-3.1 d173882dex31.htm EX-3.1 6933
4 EX-5.1 d173882dex51.htm EX-5.1 12488
5 EX-10.1 d173882dex101.htm EX-10.1 4423
9 GRAPHIC g173882snap0001.jpg GRAPHIC 2974
10 GRAPHIC g173882snap004.jpg GRAPHIC 3102
  Complete submission text file 0001193125-21-177174.txt   466315

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA onct-20210525.xsd EX-101.SCH 3073
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20210525_lab.xml EX-101.LAB 18890
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20210525_pre.xml EX-101.PRE 11862
11 EXTRACTED XBRL INSTANCE DOCUMENT d173882d8k_htm.xml XML 3572
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 21981430
SIC: 2834 Pharmaceutical Preparations